C07D 413/10
Linked by a carbon chain containing aromatic rings
Official title: linked by a carbon chain containing aromatic rings
C07D413/10 (Linked by a carbon chain containing aromatic rings) appears on 2,112 US grants and 2,292 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,112
- Published applications
- 2,292
- Assignees
- 861
- Inventors
- 7,351
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 6 | 0 |
| 1990 | 9 | 0 |
| 1991 | 12 | 0 |
| 1992 | 24 | 0 |
| 1993 | 76 | 0 |
| 1994 | 68 | 0 |
| 1995 | 48 | 0 |
| 1996 | 44 | 0 |
| 1997 | 41 | 0 |
| 1998 | 29 | 0 |
| 1999 | 34 | 0 |
| 2000 | 29 | 0 |
| 2001 | 25 | 5 |
| 2002 | 35 | 35 |
| 2003 | 37 | 43 |
| 2004 | 37 | 64 |
| 2005 | 22 | 75 |
| 2006 | 36 | 68 |
| 2007 | 38 | 69 |
| 2008 | 28 | 64 |
| 2009 | 51 | 94 |
| 2010 | 52 | 125 |
| 2011 | 55 | 131 |
| 2012 | 91 | 116 |
| 2013 | 135 | 150 |
| 2014 | 137 | 154 |
| 2015 | 132 | 115 |
| 2016 | 90 | 98 |
| 2017 | 85 | 85 |
| 2018 | 76 | 101 |
| 2019 | 67 | 103 |
| 2020 | 96 | 113 |
| 2021 | 73 | 90 |
| 2022 | 79 | 74 |
| 2023 | 46 | 108 |
| 2024 | 61 | 83 |
| 2025 | 56 | 76 |
| 2026 | 41 | 53 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof6 Oct 2026US 12,753,170 B2Akagera Medicines, Inc.
- Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof29 Sep 2026US 12,747,236 B2Akagera Medicines, Inc.
- Fluorescent ion indicators and their applications29 Sep 2026US 12,748,118 B2AAT Bioquest, Inc.
- Inhibitors and uses thereof22 Sep 2026US 12,740,991 B2Vividion Therapeutics, Inc.
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Protein kinase inhibitors and uses thereof1 Oct 2026US 2026/0297035 A1DELiver Therapeutics, Inc.
- Benzo-fused ring compound inhibitor, and preparation method therefor and use thereof1 Oct 2026US 2026/0297071 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Raf-mek protein complex modulators and methods of use thereof1 Oct 2026US 2026/0297105 A1Gandeeva Therapeutics, Inc.
- Heterocyclic derivatives, compositions and uses thereof17 Sep 2026US 2026/0274799 A1Danatlas Pharmaceuticals Co., Ltd.
- Err modulators17 Sep 2026US 2026/0274807 A1University of Health Sciences & Pharmacy in St. Louis
Most cited
By later US patents
- Oxime ester photoinitiators263US 7,759,043 B2Ciba Specialty Chemicals Corporation · 2010
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- 2,4-pyrimidinediamine compounds and their uses176US 7,557,210 B2Rigel Pharmaceuticals, Inc. · 2009
- Enzyme modulators and treatments151US 8,163,756 B2Deciphera Pharmaceuticals, LLC · 2012
- Heterocyclic containing biphenyl aP2 inhibitors and method135US 6,548,529 B1Bristol-Myers Squibb Company · 2003